Correcting the quality of the pharmaceutical industry

The quality of the product is still good, in fact, the correction is also a victim, and the capsule is not made by himself, but he can't shirk the responsibility. As such a large well-known enterprise, it is not too late to make up for such a disclosure in the procurement process.

Answer: Correction Pharmaceutical's skin care products are still good. For example, the correction group has launched a series of skin care products under the brand of "Qingzimei", specializing in the beauty and health of women's skin, and the products cover the whole line of basic skin care such as cleanser, essence, water emulsion, and cream, which have been steadily recognized by the market once they are launched.

Let's go to Du Niang for a "Starshu".

Correction of the pharmaceutical industry is better. Founded in May 1995 by Chairman Xiu Laigui, Correction Group is a concentrated collection of patent medicines, chemical pharmaceuticals and biopharmaceuticals.

scientific research, production and marketing, drug chain management.

A large-scale modern private pharmaceutical enterprise integrating the standard cultivation of Chinese herbal medicines.

It has 24 dosage forms, more than 2,000 varieties of medicines and health care products. Through secondary development, more than a dozen large varieties have been cultivated, such as Lung Ning, Xiao Mi Suppository, Liuwei Rehmannia Root, Neck and Waist Kang, and Qi and Blood Nourishing; The use of new preparation technology to develop Starshu pellets and dispersible tablets has ensured the correction of its position in the domestic gastric medicine market.

Worth.

Correction Pharmaceutical Group (hereinafter referred to as Correction Pharmaceutical) is a large-scale modern private enterprise integrating scientific research, production and marketing, with its headquarters in Changchun and its marketing headquarters in Beijing. The industrial layout has been extended from the famous pharmaceutical city to Liuhe, Shuangyang, Changchun, Beijing, Sichuan, Nanchang and other places. It covers an area of 1.17 million square meters, with a total construction area of 390,000 square meters.

The group has 66 wholly-owned subsidiaries, more than 80,000 employees, and total assets of 7.5 billion yuan.

Founded in May 1995 by Chairman Xiu Laigui, Correction Pharmaceutical Group is a large-scale modern private pharmaceutical enterprise integrating scientific research, production and marketing of patent medicines, chemical pharmaceuticals and biopharmaceuticals, drug chain management, and standard cultivation of Chinese herbal medicines.

Since 2000, it has ranked first in the comprehensive ranking of pharmaceutical enterprises in Jilin Province for 10 consecutive years, and ranked first in the profit ranking of traditional Chinese medicine enterprises in China since 2004, and ranked among the top ten in China's pharmaceutical industry in terms of sales and profits. In 2010, the output value was 16.9 billion yuan, and the sales revenue was 17.1 billion yuan. From 2000 to 2010, the cumulative sales revenue was 100 million yuan.

On July 5, 2017, the Pharmaceutical Industrial Park was amended to sign a contract with Jingmen City, Hubei Province.

Correcting all kinds of ** drugs produced by the pharmaceutical industry, every time I buy gastrointestinal medicine or the like, I will not hesitate to choose this brand. It has a high level of security and is an option for users.